BLEOMYCIN Side Effects

6735335-0 | Diffuse Large B-cell Lymphoma Stage Ii
on May 10, 2010 Female patient from SINGAPORE , 73 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and was treated with Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: diffuse large b-cell lymphoma stage ii. Bleomycin dosage: . During the same period patient was treated with DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ).

6735333-7 | Acute Myeloid Leukaemia
Patient was taking Bleomycin (View Usage). Patient had the following side effects: acute myeloid leukaemia on May 10, 2010 from SINGAPORE Additional patient health information: Female patient , 56 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Bleomycin dosage: . During the same period patient was treated with DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ).

6020645-5 | Abnormal Behaviour, Asthenia, Chloroma, Coma, Confusional State, Headache, Hemiplegia, Hypersomnia-bulimia Syndrome, Pyrexia
Adverse event was reported on Dec 09, 2008 by a Male patient taking Bleomycin (View Usage) (Dosage: 30mg Iv; Days 2, 8, And 15) was diagnosed with metastases to meninges, seminoma and. Location: ITALY , 29 years of age, After Bleomycin was administered, patient had the following side effects: abnormal behaviour, asthenia, chloroma, coma, confusional state, headache (What is headache?), hemiplegia, hypersomnia-bulimia syndrome, pyrexia. During the same period patient was treated with CISPLATIN (20mg/m2) (View Cisplatin Review and Cisplatin Label ). Patient was hospitalized.

5643728-8 | Febrile Neutropenia, Pneumomediastinum, Pulmonary Fibrosis, Pulmonary Toxicity, Respiratory Failure, Subcutaneous Emphysema
on Feb 15, 2008 Male patient from UNITED STATES , 43 years of age, was diagnosed with testis cancer and was treated with Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, pneumomediastinum, pulmonary fibrosis (What is pulmonary fibrosis?), pulmonary toxicity, respiratory failure, subcutaneous emphysema. Bleomycin dosage: 30u On Days, 1, 8 And 15. Patient was hospitalized.


5580563-3 | Cough, Dyspnoea, Pulmonary Toxicity
on Dec 31, 2007 Female patient from UNITED STATES , 56 years of age, was diagnosed with pulmonary toxicity and was treated with Bleomycin (View Usage). Patient had the following side effects: cough, dyspnoea, pulmonary toxicity. Bleomycin dosage: 10 U/m2 Q12d Iv.

5578648-0 | Chills, Dyspnoea, Hypoxia, No Therapeutic Response, Pyrexia, Therapeutic Agent Toxicity
Patient was taking Bleomycin (View Usage). After Bleomycin was administered, patient had the following side effects: chills, dyspnoea, hypoxia, no therapeutic response, pyrexia, therapeutic agent toxicity on Dec 27, 2007 from UNITED STATES Additional patient health information: Female patient , 77 years of age, weighting 157.9 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Bleomycin dosage: 17 Units Q 2wks X 7 Doses Iv. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), EMEND (View Emend Review and Emend Label ), DECADRON (View Decadron Review and Decadron Label ), ALOXI (View Aloxi Review and Aloxi Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), VELBAN (View Velban Review and Velban Label ), DTIC DOME (View Dtic-dome Review and Dtic-dome Label ). Patient was hospitalized.

5573107-3 | Hypoxia, No Therapeutic Response
Adverse event was reported on Dec 20, 2007 by a Female patient taking Bleomycin (View Usage) (Dosage: 17 Units Q 2 Wks X 7 Doses Iv) was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Location: UNITED STATES , 77 years of age, weighting 157.9 lb, Patient experienced the following unwanted or unexpected effects: hypoxia, no therapeutic response. During the same period patient was treated with ATIVAN (View Ativan Review and Ativan Label ), EMEND (View Emend Review and Emend Label ), DECADRON (View Decadron Review and Decadron Label ), ALOXI (View Aloxi Review and Aloxi Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), VELBAN (View Velban Review and Velban Label ), DTIC DOME (View Dtic-dome Review and Dtic-dome Label ). Patient was hospitalized.

5564572-6 | Testis Cancer
on Dec 03, 2007 Male patient from UNITED STATES , 30 years of age, was diagnosed with ewing's sarcoma and was treated with Bleomycin (View Usage). Patient had the following side effects: testis cancer. Bleomycin dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), DACTINOMYCIN (View Dactinomycin Review and Dactinomycin Label ).

5552874-9 | Acute Myocardial Infarction, Intracardiac Thrombus
on Nov 25, 2007 Male patient from TURKEY , 27 years of age, was diagnosed with seminoma and was treated with Bleomycin (View Usage). After Bleomycin was administered, patient had the following side effects: acute myocardial infarction, intracardiac thrombus. Bleomycin dosage: 30 Mg; Null_1_day. During the same period patient was treated with CISPLATIN (100 Mg/m**2; Null_1_day) (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (100 Mg/m**2;null_1_day) (View Etoposide Review and Etoposide Label ). Patient was hospitalized.

5549832-7 | Acute Respiratory Distress Syndrome, Pulmonary Toxicity
Patient was taking Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, pulmonary toxicity on Dec 10, 2007 from UNITED STATES Additional patient health information: Male patient , 28 years of age, was diagnosed with germ cell cancer, thoracotomy and. Bleomycin dosage: 1dosage Form=240 Units.. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), OXYGEN (View Oxygen Review and Oxygen Label ). Patient was hospitalized.

5547939-1 | Bone Swelling, Osteonecrosis
Adverse event was reported on Sep 22, 2006 by a Male patient taking Bleomycin (View Usage) (Dosage: 20 Iu Per_cycle) was diagnosed with testis cancer and. Location: UNITED KINGDOM , 25 years of age, Patient had the following side effects: bone swelling, osteonecrosis (What is osteonecrosis?). During the same period patient was treated with CISPLATIN (40 Mg/m2 Per_cycle) (View Cisplatin Review and Cisplatin Label ), DEXAMETHASONE TAB (8 Mg Per_cycle) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ).

5541608-X |
on Dec 05, 2007 Female patient from UNITED STATES , weighting 43.43 lb, was treated with Bleomycin (View Usage). . Bleomycin dosage: 12 Unit. During the same period patient was treated with CYCLOPHOSPHAMIDE (635 Mg) (View Cyclophosphamide Review and Cyclophosphamide Label ), DOXORUBICIN HYDROCHLORIDE (40 Mg) (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), ETOPOSIDE (300 Mg) (View Etoposide Review and Etoposide Label ), G CSF (FILGRASTIM, AMGEN) (600 Mg) (View G-csf (filgrastim, Amgen) Review and G-csf (filgrastim, Amgen) Label ), PREDNISONE (220.5 Mg) (View Prednisone Review and Prednisone Label ), VINCRISTINE SULFATE (2.2 Mg) (View Vincristine Sulfate Review and Vincristine Sulfate Label ). Patient was hospitalized.

5533958-8 | Cerebral Cyst, Device Leakage, Oedema
on Nov 20, 2007 Male patient from CANADA , child 12 years of age, was diagnosed with craniopharyngioma and was treated with Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebral cyst, device leakage, oedema. Bleomycin dosage: 3 Mg 3/wk Other. During the same period patient was treated with SODIUM CHLORIDE (View Sodium Chloride Review and Sodium Chloride Label ).

5533946-1 | Device Leakage, Diplopia, Eyelid Ptosis, Fatigue, Headache, Hemiparesis, Hydrocephalus, Hypothalamo-pituitary Disorder, Lethargy
Patient was taking Bleomycin (View Usage). Patient had the following side effects: device leakage, diplopia, eyelid ptosis, fatigue, headache (What is headache?), hemiparesis, hydrocephalus (What is hydrocephalus?), hypothalamo-pituitary disorder, lethargy on Nov 20, 2007 from CANADA Additional patient health information: Female patient , child 5 years of age, was diagnosed with craniopharyngioma and. Bleomycin dosage: 3 Mg 3/wk Other. During the same period patient was treated with SODIUM CHLORIDE 0.9% (View Sodium Chloride 0.9% Review and Sodium Chloride 0.9% Label ).

5533945-X | Brain Oedema, Brain Scan Abnormal, Diabetes Insipidus, Fatigue, Hypothalamo-pituitary Disorder, Injection Site Extravasation, Memory Impairment, Scar, Temperature Intolerance
Adverse event was reported on Nov 20, 2007 by a Male patient taking Bleomycin (View Usage) (Dosage: 3 Mg 3/wk Other) was diagnosed with craniopharyngioma and. Location: CANADA , child 9 years of age, After Bleomycin was administered, patient had the following side effects: brain oedema, brain scan abnormal, diabetes insipidus (What is diabetes insipidus?), fatigue, hypothalamo-pituitary disorder, injection site extravasation, memory impairment, scar (What is scar?), temperature intolerance. During the same period patient was treated with SODIUM CHLORIDE 0.9% (View Sodium Chloride 0.9% Review and Sodium Chloride 0.9% Label ). Patient was hospitalized.

5517974-8 | Hypoxia, Pulmonary Fibrosis, Respiratory Distress, Therapeutic Agent Toxicity, Upper Respiratory Tract Infection
on Nov 14, 2007 Male patient from UNITED STATES , weighting 180.0 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and was treated with Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: hypoxia, pulmonary fibrosis (What is pulmonary fibrosis?), respiratory distress, therapeutic agent toxicity, upper respiratory tract infection. Bleomycin dosage: 21 Units Every Two Weeks Intracardia. During the same period patient was treated with ALOIX (View Aloix Review and Aloix Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ADROMYCIN (View Adromycin Review and Adromycin Label ), VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ).

5468434-4 | Deep Vein Thrombosis, Febrile Neutropenia, Lung Consolidation, Nervousness, Pleural Effusion, Pneumomediastinum, Respiratory Failure, Scrotal Abscess, Subcutaneous Emphysema
on Sep 24, 2007 Male patient from NETHERLANDS , 43 years of age, was diagnosed with testis cancer and was treated with Bleomycin (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), febrile neutropenia, lung consolidation, nervousness, pleural effusion, pneumomediastinum, respiratory failure, scrotal abscess, subcutaneous emphysema. Bleomycin dosage: 30 Units On 1,8,15 Days.. During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (On Day One And Day 5.) (View Cisplatin Review and Cisplatin Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ).

5448571-0 | Acute Myeloid Leukaemia
Patient was taking Bleomycin (View Usage). After Bleomycin was administered, patient had the following side effects: acute myeloid leukaemia on Sep 10, 2007 from JAPAN Additional patient health information: Female patient , 31 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Bleomycin dosage: . During the same period patient was treated with DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ).

5425930-3 | Interstitial Lung Disease, Pneumonia Bacterial, Pulmonary Haemorrhage
Adverse event was reported on Aug 24, 2007 by a Female patient taking Bleomycin (View Usage) (Dosage: ) was diagnosed with hodgkin's disease stage iii and. Location: JAPAN , 85 years of age, Patient experienced the following unwanted or unexpected effects: interstitial lung disease, pneumonia bacterial, pulmonary haemorrhage. During the same period patient was treated with VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ). Patient was hospitalized.

5415234-7 | Groin Pain, Osteonecrosis
on Aug 10, 2007 Male patient from JAPAN , 25 years of age, was diagnosed with testis cancer, prophylaxis of nausea and vomiting and was treated with Bleomycin (View Usage). Patient had the following side effects: groin pain, osteonecrosis (What is osteonecrosis?). Bleomycin dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ).

5413270-8 | Bone Marrow Tumour Cell Infiltration, Febrile Neutropenia, Hodgkin's Disease Mixed Cellularity Recurrent, Hodgkin's Disease Mixed Cellularity Stage Iv, Leukoencephalopathy, Malignant Neoplasm Progression, Metastasis
on Jul 30, 2007 Male patient from ARGENTINA , 40 years of age, was diagnosed with hodgkin's disease stage iv and was treated with Bleomycin (View Usage). After Bleomycin was administered, patient had the following side effects: bone marrow tumour cell infiltration, febrile neutropenia, hodgkin's disease mixed cellularity recurrent, hodgkin's disease mixed cellularity stage iv, leukoencephalopathy, malignant neoplasm progression, metastasis. Bleomycin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), PROCARBAZINE HYDROCHLORIDE (View Procarbazine Hydrochloride Review and Procarbazine Hydrochloride Label ). Patient was hospitalized.

5412670-X | Acute Myeloid Leukaemia
Patient was taking Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia on Aug 10, 2007 from JAPAN Additional patient health information: Female patient , 31 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Bleomycin dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ).

5412062-3 | Lymphoid Tissue Hyperplasia, Mucoepidermoid Carcinoma
Adverse event was reported on Jul 30, 2007 by a Male patient taking Bleomycin (View Usage) (Dosage: ) was diagnosed with bone sarcoma and. Location: UNITED STATES , 17 years of age, Patient had the following side effects: lymphoid tissue hyperplasia, mucoepidermoid carcinoma. During the same period patient was treated with LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), DOXORUBICIN HYDROCHLORIDE (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), DACTINOMYCIN (View Dactinomycin Review and Dactinomycin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ).

5409109-7 | Amaurosis, Brain Oedema, Complex Partial Seizures, Epilepsy, Hemianopia
on Aug 08, 2007 Male patient from JAPAN , 14 years of age, was diagnosed with craniopharyngioma and was treated with Bleomycin (View Usage). After Bleomycin was administered, patient had the following side effects: amaurosis, brain oedema, complex partial seizures, epilepsy (What is epilepsy?), hemianopia. Bleomycin dosage: .

5407115-X | Dyspnoea, Interstitial Lung Disease
on Aug 03, 2007 Male patient from UNITED STATES , 60 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and was treated with Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, interstitial lung disease. Bleomycin dosage: 18units Other Iv.

5406932-X | Pulmonary Toxicity, Syncope
Patient was taking Bleomycin (View Usage). Patient had the following side effects: pulmonary toxicity, syncope on Aug 03, 2007 from UNITED STATES Additional patient health information: Female patient , 75 years of age, weighting 172.0 lb, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Bleomycin dosage: 20 Units Q 14 Days Iv Bolus. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), CHLORPROPAMIDE (View Chlorpropamide Review and Chlorpropamide Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

5406261-4 | Groin Pain, Osteonecrosis
Adverse event was reported on Aug 02, 2007 by a Male patient taking Bleomycin (View Usage) (Dosage: ) was diagnosed with testis cancer, prophylaxis of nausea and vomiting and. Location: JAPAN , 25 years of age, After Bleomycin was administered, patient had the following side effects: groin pain, osteonecrosis (What is osteonecrosis?). During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ).

5402943-9 | Osteonecrosis
on Jul 31, 2007 Male patient from JAPAN , 25 years of age, was diagnosed with testis cancer, prophylaxis of nausea and vomiting and was treated with Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: osteonecrosis (What is osteonecrosis?). Bleomycin dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ).

5394511-2 | Ulcer
on Jul 23, 2007 Male patient from JAPAN , 40 years of age, was treated with Bleomycin (View Usage). Patient had the following side effects: ulcer (What is ulcer?). Bleomycin dosage: . Patient was hospitalized.

5389353-8 | Asthenia, Confusional State, Constipation, Hydronephrosis, Oliguria, Pain, Pancytopenia
Patient was taking Bleomycin (View Usage). After Bleomycin was administered, patient had the following side effects: asthenia, confusional state, constipation (What is constipation?), hydronephrosis, oliguria, pain (What is pain?), pancytopenia on Jul 13, 2007 from UNITED STATES Additional patient health information: Female patient , 62 years of age, was diagnosed with cervix carcinoma and. Bleomycin dosage: . During the same period patient was treated with PLATINUM (View Platinum Review and Platinum Label ).

5382633-1 | Disseminated Intravascular Coagulation, Interstitial Lung Disease, Malignant Neoplasm Progression, Pulmonary Embolism
Adverse event was reported on Jul 09, 2007 by a Male patient taking Bleomycin (View Usage) (Dosage: ) was diagnosed with malignant mediastinal neoplasm and. Location: JAPAN , 29 years of age, Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with PARAPLATIN (View Paraplatin Review and Paraplatin Label ), VEPESID (View Vepesid Review and Vepesid Label ), RANDA (View Randa Review and Randa Label ), KYTRIL (View Kytril Review and Kytril Label ), MEYLON (View Meylon Review and Meylon Label ), DIAMOX (View Diamox Review and Diamox Label ), GRAN (View Gran Review and Gran Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ).

5370834-8 | Osteonecrosis
on Jun 25, 2007 Male patient from UNITED KINGDOM , 25 years of age, was diagnosed with testis cancer, prophylaxis of nausea and vomiting and was treated with Bleomycin (View Usage). Patient had the following side effects: osteonecrosis (What is osteonecrosis?). Bleomycin dosage: . During the same period patient was treated with CISPLATIN (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ).

5369936-1 | Deep Vein Thrombosis, Haemodialysis, Hypercoagulation, Oedema Peripheral, Pain In Extremity, Renal Failure Acute, Renal Vein Thrombosis
on Jun 11, 2007 Male patient from BRAZIL , 18 years of age, was diagnosed with testis cancer and was treated with Bleomycin (View Usage). After Bleomycin was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), haemodialysis, hypercoagulation, oedema peripheral, pain in extremity, renal failure acute, renal vein thrombosis. Bleomycin dosage: 30 Iu Per_cycle Iv. During the same period patient was treated with CISPLATIN (20 Mg/m2 Per_cycle Iv) (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (100 Mg/m2 Per_cycle Iv) (View Etoposide Review and Etoposide Label ).

5361323-5 | Bone Swelling, Osteonecrosis
Patient was taking Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: bone swelling, osteonecrosis (What is osteonecrosis?) on Jun 06, 2007 from UNITED KINGDOM Additional patient health information: Male patient , 25 years of age, was diagnosed with testis cancer, prophylaxis of nausea and vomiting and. Bleomycin dosage: 20 Iu Per_cycle. During the same period patient was treated with ETOPOSIDE (165 Mg/m2 Per_cycle) (View Etoposide Review and Etoposide Label ), CISPLATIN (40 Mg/m2 Per_cycle) (View Cisplatin Review and Cisplatin Label ), DEXAMETHASONE 0.5MG TAB (8 Mg Per_cycle Po) (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ).

5355301-X | Abdominal Pain, Anaemia, Ascites, Disseminated Intravascular Coagulation, Haemorrhage, Hepatotoxicity, Melaena, Metastases To Small Intestine, Tumour Lysis Syndrome
Adverse event was reported on Jun 07, 2007 by a Male patient taking Bleomycin (View Usage) (Dosage: ) was diagnosed with testicular cancer metastatic and. Location: JAPAN , 26 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, ascites, disseminated intravascular coagulation, haemorrhage, hepatotoxicity, melaena, metastases to small intestine, tumour lysis syndrome. During the same period patient was treated with LASTET (View Lastet Review and Lastet Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ). Patient was hospitalized.

5347139-4 | Pneumonitis
on Sep 13, 2006 Female patient from UNITED STATES , 58 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and was treated with Bleomycin (View Usage). After Bleomycin was administered, patient had the following side effects: pneumonitis. Bleomycin dosage: . During the same period patient was treated with ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ).

5337075-1 | Disseminated Intravascular Coagulation, Interstitial Lung Disease, Malignant Neoplasm Progression, Pulmonary Embolism
on May 25, 2007 Male patient from JAPAN , 29 years of age, was diagnosed with malignant mediastinal neoplasm and was treated with Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, pulmonary embolism (What is pulmonary embolism?). Bleomycin dosage: . During the same period patient was treated with PARAPLATIN (View Paraplatin Review and Paraplatin Label ), VEPESID (View Vepesid Review and Vepesid Label ), RANDA (View Randa Review and Randa Label ), KYTRIL (View Kytril Review and Kytril Label ), MEYLON (View Meylon Review and Meylon Label ), DIAMOX (View Diamox Review and Diamox Label ), GRAN (View Gran Review and Gran Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ).

5334390-2 | Disseminated Intravascular Coagulation, Interstitial Lung Disease, Malignant Neoplasm Progression, Pulmonary Embolism
Patient was taking Bleomycin (View Usage). Patient had the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, pulmonary embolism (What is pulmonary embolism?) on May 24, 2007 from JAPAN Additional patient health information: Male patient , 29 years of age, was diagnosed with malignant mediastinal neoplasm and. Bleomycin dosage: . During the same period patient was treated with PARAPLATIN (View Paraplatin Review and Paraplatin Label ), VEPESID (View Vepesid Review and Vepesid Label ), RANDA (View Randa Review and Randa Label ), KYTRIL (View Kytril Review and Kytril Label ), MEYLON (View Meylon Review and Meylon Label ), DIAMOX (View Diamox Review and Diamox Label ), GRAN (View Gran Review and Gran Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ).

5326807-4 | Disseminated Intravascular Coagulation, Interstitial Lung Disease, Malignant Neoplasm Progression, Pulmonary Embolism
Adverse event was reported on May 14, 2007 by a Male patient taking Bleomycin (View Usage) (Dosage: ) was diagnosed with malignant mediastinal neoplasm and. Location: JAPAN , 29 years of age, After Bleomycin was administered, patient had the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with PARAPLATIN (View Paraplatin Review and Paraplatin Label ), VEPESID (View Vepesid Review and Vepesid Label ), RANDA (View Randa Review and Randa Label ), KYTRIL (View Kytril Review and Kytril Label ), MEYLON (View Meylon Review and Meylon Label ), DIAMOX (View Diamox Review and Diamox Label ), GRAN (View Gran Review and Gran Label ), DIPRIVAN (View Diprivan Review and Diprivan Label ).

5325841-8 | Deep Vein Thrombosis, Haemodialysis, Renal Failure Acute, Renal Vein Thrombosis
on May 01, 2007 Male patient from BRAZIL , 18 years of age, was diagnosed with testis cancer and was treated with Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), haemodialysis, renal failure acute, renal vein thrombosis. Bleomycin dosage: 300 Iu Per_cycle Iv. During the same period patient was treated with CISPLATIN (100 Mg/m2 Per_cycle Iv) (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (100 Mg/m2 Per_cycle Iv) (View Etoposide Review and Etoposide Label ).

5316481-5 | Deep Vein Thrombosis, Haemodialysis, Renal Failure Acute, Renal Vein Thrombosis
on Apr 17, 2007 Male patient from BRAZIL , 18 years of age, was diagnosed with testis cancer and was treated with Bleomycin (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), haemodialysis, renal failure acute, renal vein thrombosis. Bleomycin dosage: 30 Iu Per_cycle Iv. During the same period patient was treated with CISPLATIN (20 Mg/m2 Per_cycle Iv) (View Cisplatin Review and Cisplatin Label ), ETOPOSIDE (100 Mg/m2 Per_cycle Iv) (View Etoposide Review and Etoposide Label ).

5313498-1 | Acute Respiratory Distress Syndrome, Creatine Urine Increased, Lung Infiltration, Pneumonitis, Reperfusion Injury, Respiratory Failure, Shock, Tumour Marker Increased
Patient was taking Bleomycin (View Usage). After Bleomycin was administered, patient had the following side effects: acute respiratory distress syndrome, creatine urine increased, lung infiltration, pneumonitis, reperfusion injury, respiratory failure, shock, tumour marker increased on Apr 09, 2007 from AUSTRALIA Additional patient health information: Male patient , 27 years of age, was diagnosed with testicular germ cell cancer, oxygen supplementation and. Bleomycin dosage: . During the same period patient was treated with OXYGEN (View Oxygen Review and Oxygen Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), WHOLE BLOOD (View Whole Blood Review and Whole Blood Label ).

5302066-3 | Deep Vein Thrombosis, Pulmonary Embolism
Adverse event was reported on Apr 18, 2007 by a Male patient taking Bleomycin (View Usage) (Dosage: ) was diagnosed with testis cancer and. Location: UNITED KINGDOM , 39 years of age, weighting 178.6 lb, Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with CALCICHEW D3 (View Calcichew D3 Review and Calcichew D3 Label ), CARBOPLATIN (View Carboplatin Review and Carboplatin Label ), CHLORHEXIDINE GLUCONATE (View Chlorhexidine Gluconate Review and Chlorhexidine Gluconate Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), CLARITHROMYCIN (View Clarithromycin Review and Clarithromycin Label ), CODEINE (View Codeine Review and Codeine Label ), CYCLIZINE HCL (View Cyclizine Hcl Review and Cyclizine Hcl Label ).

5297738-3 | Blood Ph Decreased, Pneumonitis, Respiratory Failure, Shock
on Mar 12, 2007 Male patient from AUSTRALIA , 27 years of age, was diagnosed with lymphadenopathy and was treated with Bleomycin (View Usage). Patient had the following side effects: blood ph decreased, pneumonitis, respiratory failure, shock. Bleomycin dosage: (4 Cycles). During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ). Patient was hospitalized.

5296242-6 | Abdominal Pain, Anaemia, Ascites, Disseminated Intravascular Coagulation, Haemorrhage, Hepatotoxicity, Melaena, Metastases To Small Intestine, Tumour Lysis Syndrome
on Apr 11, 2007 Male patient from JAPAN , 26 years of age, was diagnosed with testicular cancer metastatic and was treated with Bleomycin (View Usage). After Bleomycin was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), anaemia, ascites, disseminated intravascular coagulation, haemorrhage, hepatotoxicity, melaena, metastases to small intestine, tumour lysis syndrome. Bleomycin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ).

5288621-8 | Disease Progression, Hodgkin's Disease, Immunosuppression, Interstitial Lung Disease, Lung Neoplasm, Lymphadenopathy, Sarcoidosis, Treatment Noncompliance
Patient was taking Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, hodgkin's disease (What is hodgkin's disease?), immunosuppression, interstitial lung disease, lung neoplasm, lymphadenopathy, sarcoidosis, treatment noncompliance on Mar 19, 2007 from POLAND Additional patient health information: Male patient , 25 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Bleomycin dosage: . During the same period patient was treated with DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ), CORTICOSTEROID (View Corticosteroid Review and Corticosteroid Label ).

5285982-0 | Carotid Artery Thrombosis
Adverse event was reported on Mar 29, 2007 by a Female patient taking Bleomycin (View Usage) (Dosage: ) was diagnosed with hodgkin's disease (What is hodgkin's disease?) and. Location: ITALY , 25 years of age, Patient had the following side effects: carotid artery thrombosis. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ), VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ).

5278780-5 | Carotid Artery Thrombosis
on Mar 26, 2007 Female patient from ITALY , 25 years of age, was diagnosed with hodgkin's disease (What is hodgkin's disease?) and was treated with Bleomycin (View Usage). After Bleomycin was administered, patient had the following side effects: carotid artery thrombosis. Bleomycin dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), DACARBAZINE (View Dacarbazine Review and Dacarbazine Label ), VINBLASTINE SULFATE (View Vinblastine Sulfate Review and Vinblastine Sulfate Label ).

5272656-5 | Disease Progression, Respiratory Failure, Shock
on Mar 20, 2007 Male patient from AUSTRALIA , 27 years of age, was diagnosed with retroperitoneal cancer and was treated with Bleomycin (View Usage). Patient experienced the following unwanted or unexpected effects: disease progression, respiratory failure, shock. Bleomycin dosage: . During the same period patient was treated with ETOPOSIDE (View Etoposide Review and Etoposide Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), IFOSFAMIDE (View Ifosfamide Review and Ifosfamide Label ), PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), PIPERACILLIN (View Piperacillin Review and Piperacillin Label ), TAZOBACTAM SODIUM (View Tazobactam Sodium Review and Tazobactam Sodium Label ), NITROUS OXIDE W/ OXYGEN (View Nitrous Oxide W/ Oxygen Review and Nitrous Oxide W/ Oxygen Label ). Patient was hospitalized.

5267604-8 | Azoospermia
Patient was taking Bleomycin (View Usage). Patient had the following side effects: azoospermia on Mar 05, 2007 from JAPAN Additional patient health information: Male patient , 33 years of age, was diagnosed with testicular seminoma (pure) and. Bleomycin dosage: . During the same period patient was treated with LASTET (View Lastet Review and Lastet Label ), RANDA (View Randa Review and Randa Label ).